N/A 

 

ARCH VENTURE PARTNERS X, L.P. 

DIRECTOR

ARCH VENTURE FUND X, L.P.

N/A 

 

ARCH VENTURE PARTNERS X, LLC 

DIRECTOR

ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.

KRISTINA 

 

BUROW 

EXECUTIVE OFFICER

KILIMANJARO ENERGY, INC.   |  LIMERICK BIOPHARMA INC   |  RECEPTOS, INC.   |  TRELYS, INC.   |  CENEXYS, INC.   |  LYCERA CORP   |  ARCH VENTURE FUND VIII, L.P.   |  AGBIOME, LLC   |  METACRINE, INC.   |  SIENNA LABS, INC.   |  SCHOLAR ROCK LLC   |  UNITY BIOTECHNOLOGY, INC.   |  ARCH VENTURE FUND IX, L.P.   |  BORAGEN, INC.   |  SIENNA BIOPHARMACEUTICALS, INC.   |  SCHOLAR ROCK HOLDING CORP   |  GOSSAMER BIO, INC.   |  VIR BIOTECHNOLOGY, INC.   |  BEAM THERAPEUTICS INC.   |  VIVIDION THERAPEUTICS, INC.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  BOUNDLESS BIO, INC.   |  ARCH VENTURE FUND XI, L.P.   |  TREELINE BIOSCIENCES, INC.   |  ARCH VENTURE FUND XII, L.P.   |  NEUMORA THERAPEUTICS, INC.   |  MIRADOR THERAPEUTICS, INC.   |  AUTOBAHN THERAPEUTICS, INC.   |  METSERA, INC.

KEITH 

L. 

CRANDELL 

EXECUTIVE OFFICER

QUANTERIX CORP   |  NEWCO LS15, INC.   |  PERMEON BIOLOGICS, INC.   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  CYTRELLIS BIOSYSTEMS, INC.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.

STEVEN 

 

GILLIS 

EXECUTIVE OFFICER

TRUBION PHARMACEUTICALS, INC   |  PHASERX INC   |  PULMATRIX INC   |  THERACLONE SCIENCES, INC.   |  MIRINA CORP   |  SURFACE LOGIX INC   |  ACYLIN THERAPEUTICS, INC.   |  BLUEBIRD BIO, INC.   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  GROOVE BIOPHARMA CORP   |  ALLOZYNE INC   |  PHASERX, INC.   |  VIRAL LOGIC SYSTEMS TECHNOLOGY CORP   |  FARADAY PHARMACEUTICALS, INC.   |  PULMATRIX OPERATING COMPANY, INC.   |  LYCERA CORP   |  PULMATRIX, INC.   |  NEXGENIA INC.   |  CODIAK BIOSCIENCES, INC.   |  VBI VACCINES INC/BC   |  NOHLA THERAPEUTICS INC.   |  HOMOLOGY MEDICINES, INC.   |  IMMUSANT, INC.   |  ONCORESPONSE INC   |  EGENESIS, INC.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  ARCH VENTURE FUND XI, L.P.   |  HC BIOSCIENCE, INC.   |  ARCH VENTURE FUND XII, L.P.   |  PHEAST THERAPEUTICS, INC.   |  SONOTHERA, INC.   |  PRONIRAS CORP   |  ONCORESPONSE, INC

MARK 

 

MCDONNELL 

EXECUTIVE OFFICER

BALYASNY DEDICATED INVESTOR OFFSHORE FUND, LTD.   |  ATLAS FUNDAMENTAL TRADING FUND, LTD   |  UNIVA CORP   |  BAM ZIE FUND, LTD   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.

ROBERT 

T. 

NELSEN 

EXECUTIVE OFFICER

IKARIA HOLDINGS INC   |  FATE THERAPEUTICS INC   |  NEUROGESX INC   |  SAGE THERAPEUTICS, INC.   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  GRAIL, INC.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.

PAUL 

 

THURK 

EXECUTIVE OFFICER

ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.